Navigation Links
Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
Date:12/10/2007

pharmacokinetics. These data were presented today by Dr. Lancet in the "Acute Myeloid Leukemias: Therapy, excluding Transplantation-Novel Therapies" oral session.

"We are pleased to report these promising results from our Phase 1 trial of SNS-595 in advanced leukemia patients. We believe three significant observations have emerged from this study: SNS-595 demonstrates anticancer activity among patients with advanced disease; SNS-595 is generally well tolerated -- even among elderly patients; and SNS-595 may be administered on either a once- or twice-weekly schedule," said Daniel C. Adelman, M.D., Sunesis' Senior Vice President, Development and Chief Medical Officer. "Data from our Phase 1 clinical trial provide strong support for our development plans for SNS-595 as a single agent and in combination with other anti-leukemic agents, such as cytarabine."

Poster Presentation: Mechanism of Action of SNS-032, a Novel Cyclin-Dependent Kinase Inhibitor, in Chronic Lymphocytic Leukemia: Comparison with Flavopiridol (Abstract # 3112)

Results from a non-clinical study of SNS-032, a potent and selective inhibitor of CDKs 2, 7 and 9, further characterized SNS-032's potential mechanism of action and favorably compared SNS-032's in vitro activity with flavopiridol in CLL cells obtained from patients.

SNS-032 acts by inhibiting the activity of CDKs 7 and 9 and reducing RNA synthesis, as well as down-regulating the expression of anti-apoptotic proteins, such as myeloid cell leukemia sequence 1, or MCL-1, and X-linked Inhibitor of Apoptosis Protein, or XIAP, both of which are associated with CLL-cell survival and proliferation. SNS-032 induces apoptosis in CLL cells, and its activity appears to be independent of p53 activity. This profile is significant as loss of p53 function has been implicated in the development of drug resistance with other agents. In a direct comparison, SNS-032 was more potent than flavopiridol in CLL cells. In addition, SNS-032 de
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Beach, FL (PRWEB) December 15, 2014 South ... , knows that holidays can be a daze of hassle, ... slips and falls while decking halls, to burns when making ... of holiday hazards that can happen at any time. To ... pain, MD Now has made a list of helpful and ...
(Date:12/15/2014)... December 15, 2014 Health Dialog, ... announced today that it has received Patient Oriented ... (NCQA) for its Disease Management (DM) Programs for ... (COPD), coronary heart disease and diabetes. This marks ... for Health Dialog’s Disease Management (DM) Programs, reaffirming ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing ... factors which is contributing to the growth in the global ... treatment of hearing loss and balance disorders are known as ... microphone, speaker and amplifier. The global market is expected to ... the period from 2014 to 2019. Some of the factors ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
(Date:12/15/2014)... 2014 Kenmode Precision Metal Stamping has ... Director of Quality Assurance. He brings more than ... and certifications for manufacturers in the U.S. and abroad. ... Quality Manager at Sonoco Products Company in the Protective ... and Quality Assurance Manager for Prince Industries, all in ...
Breaking Medicine News(10 mins):Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2
... turning to massage for relief, EVANSTON, Ill., Sept. ... to massage therapy for relaxation, according to the 12th,annual ... The survey found that 59 percent of Americans are,more ... relaxation are the,top reasons Americans received their last massage. ...
... supplier of replacement medical repair parts for hospital,equipment, was ... INC 500,for healthcare. This marks the third straight year ... of the fastest growing companies in,America., "We are ... INC,magazine recognize our tremendous growth," said President & CEO ...
... Locator Available on, http://www.flucliniclocator.org, Helps People Find ... 24 The American Lung,Association is making it ... flu shot,this season with the availability of its ... public influenza vaccination clinics is now,available at ...
... the United States are highest among African Americans, but a ... incidence and death between African Americans and whites is declining. ... cases) between the races is equal, although the death rate ... , The report will be published in an upcoming ...
... are among the 31 nationwide who have received ... of Health. The awards are designed "to enable ... transform biomedical and behavioral science." , The grants, ... five years, were awarded to Yuriy Kirichok, PhD, ...
... is playing an ever smaller role in the treatment ... and safe radiation therapy techniques. Progress in radiation technology ... This is according to Professor Freek Beekman, who will ... on Wednesday, 24 September. , In his inaugural ...
Cached Medicine News:Health News:Massage Therapy Use Holds Steady, Despite Lagging Economy 2Health News:Massage Therapy Use Holds Steady, Despite Lagging Economy 3Health News:American Lung Association Joins Health Officials to Prevent the Spread of Influenza by Urging People to Get Vaccinated 2Health News:American Lung Association Joins Health Officials to Prevent the Spread of Influenza by Urging People to Get Vaccinated 3Health News:American Lung Association Joins Health Officials to Prevent the Spread of Influenza by Urging People to Get Vaccinated 4Health News:Racial disparities decline for cancer in Missouri 2Health News:Racial disparities decline for cancer in Missouri 3Health News:2 UCSF scientists recognized for transformative research 2Health News:2 UCSF scientists recognized for transformative research 3Health News:Open cancer surgery set to become a thing of the past 2
(Date:12/15/2014)... , Dec. 15, 2014 As medical ... (Structured Product Labeling) markup language standard, content teams have ... and skills to work with the standard. Starting January ... of three webinars on the benefits and the critical ... webinars will be facilitated by Howard Shatz , ...
(Date:12/15/2014)... and BOSTON , December ... leading GPCR structure-guided drug discovery and development company, is ... in the United States relating ... these patents in the US significantly strengthens the global ... major pharmaceutical markets. The suite of patents ...
(Date:12/13/2014)... CHICAGO , Dec. 12, 2014  Radiologists ... access to images, to their referring physicians, electronic ... effectively using carefully selected technology.  ... Advanced Data Systems Corporation (ADS) at the recent ... Chicago.  The transmitting of radiology reports in this ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information....
... The OmniMD Medical Billing system allows ... and accounting. It is integrated with ... capture. The system interfaces with electronic ... tracking. With a set of reports, ...
... Amylase CPNG3 single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Amylase CPNG3 reagent provides a long ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
Medicine Products: